Cardlytics Inc (NASDAQ:CDLX) shares, rose in value on Thursday, July 10, with the stock price up by 0.56% to the previous day’s close as strong demand from buyers drove the stock to $1.79.
Actively observing the price movement in the last trading, the stock closed the session at $1.78, falling within a range of $1.73 and $1.91. The value of beta (5-year monthly) was 1.259. Referring to stock’s 52-week performance, its high was $9.48, and the low was $1.22. On the whole, CDLX has fluctuated by 0.00% over the past month.
With the market capitalization of Cardlytics Inc currently standing at about $93.97 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-07.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CDLX’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CDLX currently trading nearly 3.32% and -1.39% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 51.44, while the 7-day volatility ratio is showing 10.09% which for the 30-day chart, stands at 11.31%. Furthermore, Cardlytics Inc (CDLX)’s beta value is 1.25.
A comparison of Cardlytics Inc (CDLX) with its peers suggests the former has fared considerably weaker in the market. CDLX showed an intraday change of 0.56% in last session, and over the past year, it shrunk by -51.75%%.
Data on historical trading for Cardlytics Inc (NASDAQ:CDLX) indicates that the trading volumes over the past 10 days have averaged 1.51 and over the past 3 months, they’ve averaged 960.17K. According to company’s latest data on outstanding shares, there are 52.17 million shares outstanding.
Nearly 5.20% of Cardlytics Inc’s shares belong to company insiders and institutional investors own 54.57% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.02 million shares as on 2025-06-13, resulting in a short ratio of 12.92. According to the data, the short interest in Cardlytics Inc (CDLX) stood at 1784.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 8.33 million. The stock has fallen by -78.20% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CDLX stock heading into the next quarter.
